[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366805-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366805-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pan-cancer-multi-omics-profiling-of-ms4a2-unveils-its-functional-landscape-in-lung-adenocarcinoma","Pan-cancer multi-omics profiling of MS4A2 unveils its functional landscape in lung adenocarcinoma","","Pan-cancer multi-omics profiling identifies MS4A2 as a mast cell-associated component with paradoxical, context-dependent roles in cancer progression. Using integrated bulk RNA-seq across TCGA/GTEx cancers and single-cell transcriptomics in NSCLC cohorts, the study quantifies prognostic effects across OS, DSS, PFI, and DFI via Cox and Kaplan–Meier models. Results show LUAD-specific prognostic dominance, female-biased and stage-dependent expression, and associations with 5-fluorouracil and axitinib sensitivity, alongside bidirectional chemokine polarization that shapes an immunosuppressive niche.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-multi-omics-profiling-of-ms4a2-unveils-its-functional-landscape-in-lung-adenocarcinoma/366805/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-multi-omics-profiling-of-ms4a2-unveils-its-functional-landscape-in-lung-adenocarcinoma/366805.png","ImageObject",300,407,{"name":42,"@type":43},"awa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study about MS4A2 in lung adenocarcinoma?","Question",{"text":63,"@type":64},"The study characterizes MS4A2’s functional landscape and prognostic impact in lung adenocarcinoma using pan-cancer multi-omics evidence across multiple survival endpoints.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were prognostic effects of MS4A2 quantified for OS, DSS, PFI, and DFI?",{"text":68,"@type":64},"Prognostic impacts were evaluated using Cox regression and Kaplan–Meier modeling for all four survival endpoints, complemented by immune infiltration and methylation-epigenetic correlation analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"What cellular mechanism links MS4A2 to the tumor microenvironment in LUAD?",{"text":72,"@type":64},"Single-cell mapping localizes MS4A2 to tumor-associated mast cells, where it regulates chemokine networks that suppress lymphoid homing while enhancing myeloid recruitment and leukocyte transendothelial migration.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366805,1790195293,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Experimental Research  \nPan-cancer multi-omics profiling of MS4A2 unveils its functional landscape in lung adenocarcinoma  \nBitian Zhang, MSca , William Chi-Shing Cho, PhDb , Ping-Chung Leung, MDa , Chun-Kwok Wong, PhDa,c,d ,*, Dongjie Wang, PhDa,e ,*  \nBackground: The membrane-spanning 4-domains subfamily A member 2 (MS4A2), a mast cell-specific IgE receptor component, exhibits paradoxical roles in cancer progression. While pan-cancer analyses suggest its context-dependent duality, its prognostic hierarchy across survival metrics – overall survival (OS), disease-specific survival (DSS), progression-free interval (PFI), and disease-free interval (DFI)– remains uncharacterized in lung adenocarcinoma (LUAD) .  \nMaterials and methods: We integrated bulk RNA-seq (TCGA/GTEx, 33 cancers) and single-cell transcriptomics (NSCLC cohorts) to map MS4A2’s expression dynamics. Prognostic impacts were quantified through Cox regression and Kaplan–Meier modeling for all four survival endpoints (OS/DSS/PFI/DFI), complemented by immune infiltration and methylation-epigenetic correlation analyses. Drug sensitivity associations were evaluated using GDSC pharmacogenomics.  \nResults: Pan-cancer stratification revealed LUAD-specific prognostic dominance of MS4A2, with elevated expression reducing mortality risk (OS HR = 0.58, DSS HR = 0.61; all P \u003C 0.05) and prolonging disease control (PFI HR = 0.59, DFI HR = 0.59; all P \u003C 0.05) . Single-cell mapping localized MS4A2 to tumor-associated mast cells, where its bidirectional chemokine regulation – suppressing lymphoid homing (CCL19/CCL21) while amplifying myeloid recruitment (CCL20/CXCL8)– orchestrated leukocyte transendothelial migration. Clinically, MS4A2 exhibited female-biased expression (P \u003C 0.01) and stage-dependent attenuation (P \u003C 0.01), correlating with enhanced sensitivity to 5-fluorouracil and axitinib (P \u003C 0.05) in high-expressing tumors despite their immune-evasive traits. Conclusion: By converging multi-omics evidence across four prognostic axes (OS/DSS/PFI/DFI), we redefine MS4A2 as a mast cell-driven gatekeeper of LUAD progression. Its dual chemokine polarization establishes an immunosuppressive niche paradoxically susceptible to cytotoxic agents, proposing a precision stratification framework: MS4A2 high tumors for 5-FU/axitinib regimens combined with immunotherapies to counterbalance microenvironmental resistance. This quad-metric prognostic model advances LUAD management by linking mast cell biology to clinically actionable survival endpoints.  \nKeywords: lung adenocarcinoma, mast cell, MS4A2, pan-cancer, tumor microenvironment  \nIntroduction  \nGlobally, cancer remains a major public health challenge, with the latest 2024 statistics indicating a continued rise in incidence and mortality rates[1] . 19.3 million cancer cases were newly diagnosed in 2020 and this population will increase to 29.4 million worldwide in 2040[2] . Amidst this escalating burden, molecular drivers exhibiting tissue-specific oncogenic  \naInstitute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications ofMedicinal Plants, The Chinese University of HongKong, Hong Kong, China, bDepartment of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong China, cDepartment of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China, dLiDak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China and eShenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China  \nSponsorships or competing interests that may be relevant to content are disclosed at the end of this article.  \n*Corresponding authors. Address: Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT Hong Kong, China. [E-mail: ck-wong@cuhk.edu.hk](E-mail: ck-wong@cuhk.edu.hk) (C-K. Wong); Institute of Chinese Medicine and State Key Laboratory of Research on B","cbCaiseki8OuZpgE","https://ap.wps.com/l/cbCaiseki8OuZpgE","pdf",3850719,12,"English","# Introduction\n## Background\n## Materials and methods\n## Results\n## Conclusion","[{\"question\":\"What is the main focus of the study about MS4A2 in lung adenocarcinoma?\",\"answer\":\"The study characterizes MS4A2’s functional landscape and prognostic impact in lung adenocarcinoma using pan-cancer multi-omics evidence across multiple survival endpoints.\"},{\"question\":\"How were prognostic effects of MS4A2 quantified for OS, DSS, PFI, and DFI?\",\"answer\":\"Prognostic impacts were evaluated using Cox regression and Kaplan–Meier modeling for all four survival endpoints, complemented by immune infiltration and methylation-epigenetic correlation analyses.\"},{\"question\":\"What cellular mechanism links MS4A2 to the tumor microenvironment in LUAD?\",\"answer\":\"Single-cell mapping localizes MS4A2 to tumor-associated mast cells, where it regulates chemokine networks that suppress lymphoid homing while enhancing myeloid recruitment and leukocyte transendothelial migration.\"}]","Pan-cancer multi-omics profiling of MS4A2 unveils its functional landscape in lung adenocarcinoma | PDF",1790167605,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2354d0c5ba0fe7d500acdc84782a6eb0.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2def1d0e15761ec6f399978dc87df363.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6220ad7591536ca2aa296a669a3776ea.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4477d16c3c564cadd035490cea4c3312.webp",980,1306]